Interpace Diagnostics Group, based in New Haven, offers a range of molecular and first line diagnostic tests designed to evaluate the risk of cancer.
The company provides clinically useful services that aid in the early detection and management of cancer, helping patients and healthcare providers make informed decisions about treatment options.
Generated from their website's infomation